BOLD Q1 2019 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$52M

Net Income

-$49M

EPS (Diluted)

$-1.12

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$44M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$455M

Total Liabilities

$53M

Stockholders' Equity

$402M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$52M	-$26M	-96.3%
Net Income	-$49M	-$26M	-93.2%